Bloomberg Billionaires Index

View profiles for each of the world’s 500 richest people, see the biggest movers, and compare fortunes or track returns.

# 367 Du Weimin $5.46B

Random fact: Shenzhen Kangtai was a state-owned company when it was founded in 1992.

Overview

Du is the chairman of Shenzhen Kangtai Biological Products, a vaccine manufacturer in China. The Shenzhen-based business reported revenue of 2 billion yuan ($305 million) in 2018. It has two research centers and industrial bases in China and started trading publicly on the country's ChiNext board in 2017.

As of :
Last change +$79.1M ( +1.5%)
YTD change +$1.46B ( +36.5%)
Industry Health Care
Biggest asset 300601 CH Equity
Citizenship China
Age 57
Wealth Self-made
View net worth over:   Max 1 year 1 quarter 1 month 1 week

Relative Value

Du Weimin's net worth of $5.46B can buy ...

0
troy ounces of gold
0
barrels of crude oil

... and is equivalent to ...

0%
of the GDP of the United States
0%
of the total wealth of the 500 richest people in the world
0%
of the top 100 U.S. college endowments
0%
of the top 200 U.S. executives’ total awarded compensation
0%
of U.S. existing home sales
0
times the median U.S. household income

Latest News

Net Worth Summary

Cash
Private asset
Public asset
Misc. liabilities
Confidence rating:

Du's fortune is derived from his 53% stake of Shenzhen Kangtai Biological Products, a vaccine manufacturer in China. The Shenzhen-based business reported revenue of 2 billion yuan ($305 million) in 2018, according to the company's annual report.

He holds the stake directly, according to the company's 2019 third-quarter report. About 7% of his shares are pledged and removed from the net worth calculation.

A liability is applied based on an analysis of historical transactions, dividends, stock performance and taxes.

Biography

Birthdate: 1/1/1963
Family: Unmarried, No children
Education: Jinan University

Du was born in 1963 into a farming fmaily. He studied chemistry at college and began work in a clinic in Jiangxi province in China as a lab researcher in September 1987.

He became a sales manager for a biological technology company in 1995, according to the company's prospectus for initial public offering in 2017.

Du founded Beijing Minhai Biotechnology in 2004.

Shenzhen Kangtai was a state-owned company when it was founded in 1992 and became a private enterprise in 2008.

Du became the largest shareholder of Shenzhen Kangtai when it acquired Du's Beijing Minhai biotechnology company. He's been chairman of Shenzhen Kangtai since September 2008.

Milestones
  • 1992 Company is founded.
  • 1998 Obtains official license from China's regulator for drugs.
  • 2008 Acquires Beijing Minhai Biotechnology.
  • 2017 Starts trading publicly on the Shenzhen Stock Exchange.